Increased and unique ability to generate other cell types.
Unique capacity to self-multiply and give rise…
Omnigen’s new progressive and innovating service.
Omnigen’s advantages help you make the right choice.
Research and new treatments from Omnigen
Omnigen is one of the most modern and complete biotechnology companies. We are active in cryopreservation of stem cells, cell therapy and regenerative medicine. Our primary purpose is to offer to the public the real benefits of science and by seeking continuous development, to provide complete and specialized services. Stem cells are primitive human cells and the source of organs and tissues that form our body. In Omnigen we isolate and store hematopoietic (HSC) and mesenchymal (MSC) stem cells from the umbilical cord blood and tissue. We follow the most modern and safe methods abiding to the European directives for the operation of the cord blood and tissue banks. We use state of the art equipment.
By running continuous tests we ensure the quality of our services. After systematic controls of the samples after cryopreservation and thawing procedure, Omnigen achieved viability greater than 90% in comparison to the initial number of cryopreserved HSCs (CD34 +).
With our mind in future parents, we expand our offered services for a more integral care. Now in our laboratories, we isolate and cryopreserve MSCs from dental pulp and we offer a series of molecular tests: Cystic Fibrosis, Thrombophilia, PAP test, male fertility, HPV.
Omnigen is founding member of Hellenic Cord Blood Banks Union (EETOA) assuring parents for the future of the stored stem cells in the unlike situation the company ceases its operation.
Omnigen’s family bank hold accreditations from the Hellenic Accreditation System (ESYD), Lloyds Register for the international quality standard ISO 9001:2008 and applies all ther Good Manufacture Practices (GMP).
Contact us for more information at +30 210 6810300 or using our contact form